Filing Details
- Accession Number:
- 0001567619-20-009372
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-08 17:00:20
- Reporting Period:
- 2020-05-04
- Accepted Time:
- 2020-05-08 17:00:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1184149 | W Jonathan Ayers | One Idexx Drive Westbrook ME 04092 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-05-04 | 15,000 | $268.34 | 122,600 | No | 4 | S | Indirect | by Ayers Family Trust |
| Common Stock | Disposition | 2020-05-06 | 13,600 | $286.07 | 109,000 | No | 4 | S | Indirect | by Ayers Family Trust |
| Common Stock | Disposition | 2020-05-07 | 11,000 | $292.25 | 98,000 | No | 4 | S | Indirect | by Ayers Family Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | by Ayers Family Trust |
| No | 4 | S | Indirect | by Ayers Family Trust |
| No | 4 | S | Indirect | by Ayers Family Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Deferred Stock Unit | Acquisiton | 2020-05-06 | 370 | $0.00 | 370 | $0.00 |
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Acquisiton | 2020-05-06 | 1,279 | $0.00 | 1,279 | $283.59 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 584 | No | 4 | A | Direct | ||
| 1,279 | 2030-05-05 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 810,467 | Direct |
Footnotes
- Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2021 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors.
- Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2021 annual meeting of shareholders, whichever event is earlier.
- Not applicable.
Billionaire Hedge Funds
